छोड़कर सामग्री पर जाएँ
Buy Voltas; target of Rs 1230: Motilal Oswal

Buy Voltas; target of Rs 1230: Motilal Oswal

Motilal Oswal is bullish on Voltas recommended buy rating on the stock with a target price of Rs 1230 in its research report dated January 31, 2024.

Read More

​ Motilal Oswal is bullish on Voltas recommended buy rating on the stock with a target price of Rs 1230 in its research report dated January 31, 2024. Motilal Oswal is bullish on Voltas recommended buy rating on the stock with a target price of Rs 1230 in its research report dated January 31, 2024.  Moneycontrol Latest News Read More  

Motilal Oswal is bullish on Voltas recommended buy rating on the stock with a target price of Rs 1230 in its research report dated January 31, 2024.

Buy Dabur; target of Rs 635: Motilal Oswal

Buy Dabur; target of Rs 635: Motilal Oswal

Motilal Oswal is bullish on Dabur recommended buy rating on the stock with a target price of Rs 635 in its research report dated January 31, 2024.

Read More

​ Motilal Oswal is bullish on Dabur recommended buy rating on the stock with a target price of Rs 635 in its research report dated January 31, 2024. Motilal Oswal is bullish on Dabur recommended buy rating on the stock with a target price of Rs 635 in its research report dated January 31, 2024.  Moneycontrol Latest News Read More  

Motilal Oswal is bullish on Dabur recommended buy rating on the stock with a target price of Rs 635 in its research report dated January 31, 2024.

Buy Sun Pharma; target of Rs 1635: Motilal Oswal

Buy Sun Pharma; target of Rs 1635: Motilal Oswal

Motilal Oswal is bullish on Sun Pharma recommended buy rating on the stock with a target price of Rs 1635 in its research report dated January 31, 2024.

Read More

​ Motilal Oswal is bullish on Sun Pharma recommended buy rating on the stock with a target price of Rs 1635 in its research report dated January 31, 2024. Motilal Oswal is bullish on Sun Pharma recommended buy rating on the stock with a target price of Rs 1635 in its research report dated January 31, 2024.  Moneycontrol Latest News Read More  

Motilal Oswal is bullish on Sun Pharma recommended buy rating on the stock with a target price of Rs 1635 in its research report dated January 31, 2024.

Rashi Peripherals IPO: Should you subscribe to the Rs 600-crore issue?

Rashi Peripherals IPO: Should you subscribe to the Rs 600-crore issue?

The price band for the issue has been fixed at Rs 295-311 per share. The Rs 600-crore IPO is entirely a fresh issue of 1.93 crore shares

Read More

​ The price band for the issue has been fixed at Rs 295-311 per share. The Rs 600-crore IPO is entirely a fresh issue of 1.93 crore shares The price band for the issue has been fixed at Rs 295-311 per share. The Rs 600-crore IPO is entirely a fresh issue of 1.93 crore shares  Moneycontrol Latest News Read More  

The price band for the issue has been fixed at Rs 295-311 per share. The Rs 600-crore IPO is entirely a fresh issue of 1.93 crore shares

Sobha Q3 profit falls 53% to Rs 15 crore

Sobha Q3 profit falls 53% to Rs 15 crore

Its net profit stood at Rs 31.8 crore in the year-ago period.

Read More

​ Its net profit stood at Rs 31.8 crore in the year-ago period. Its net profit stood at Rs 31.8 crore in the year-ago period.  Moneycontrol Latest News Read More  

Its net profit stood at Rs 31.8 crore in the year-ago period.

Rashi Peripherals IPO fully subscribed on 1st day of bidding with retail, HNI support

Rashi Peripherals IPO fully subscribed on 1st day of bidding with retail, HNI support

Rashi Peripherals IPO: The Mumbai-based company aims to raise Rs 600 crore through IPO, which comprises only a fresh issue component.

Read More

​ Rashi Peripherals IPO: The Mumbai-based company aims to raise Rs 600 crore through IPO, which comprises only a fresh issue component. Rashi Peripherals IPO: The Mumbai-based company aims to raise Rs 600 crore through IPO, which comprises only a fresh issue component.  Moneycontrol Latest News Read More  

Rashi Peripherals IPO: The Mumbai-based company aims to raise Rs 600 crore through IPO, which comprises only a fresh issue component.

Virat Kohli likely to end endorsement deal with Puma India: Report

Virat Kohli likely to end endorsement deal with Puma India: Report

The sports and athleisure brand had signed Kohli in 2017 in a deal amounting to Rs 110 crore. Kohli had become the first Indian sportsperson to sign an over Rs 100 crore deal.

Read More

​ The sports and athleisure brand had signed Kohli in 2017 in a deal amounting to Rs 110 crore. Kohli had become the first Indian sportsperson to sign an over Rs 100 crore deal. The sports and athleisure brand had signed Kohli in 2017 in a deal amounting to Rs 110 crore. Kohli had become the first Indian sportsperson to sign an over Rs 100 crore deal.  Moneycontrol Latest News Read More  

The sports and athleisure brand had signed Kohli in 2017 in a deal amounting to Rs 110 crore. Kohli had become the first Indian sportsperson to sign an over Rs 100 crore deal.

Kalpataru Projects International profit rises over 32% to Rs 144 crore in Q3

Kalpataru Projects International profit rises over 32% to Rs 144 crore in Q3

Its profit stood at Rs 109 crore in the quarter ended on December 31, 2022, a regulatory filing showed.

Read More

​ Its profit stood at Rs 109 crore in the quarter ended on December 31, 2022, a regulatory filing showed. Its profit stood at Rs 109 crore in the quarter ended on December 31, 2022, a regulatory filing showed.  Moneycontrol Latest News Read More  

Its profit stood at Rs 109 crore in the quarter ended on December 31, 2022, a regulatory filing showed.

Kalpataru Projects International profit rises over 32% to Rs 144 crore in Q3

Kalpataru Projects International profit rises over 32% to Rs 144 crore in Q3

Its profit stood at Rs 109 crore in the quarter ended on December 31, 2022, a regulatory filing showed.

Read More

​ Its profit stood at Rs 109 crore in the quarter ended on December 31, 2022, a regulatory filing showed. Its profit stood at Rs 109 crore in the quarter ended on December 31, 2022, a regulatory filing showed.  Moneycontrol Latest News Read More  

Its profit stood at Rs 109 crore in the quarter ended on December 31, 2022, a regulatory filing showed.

How to choose the right tax-saver 80C investments before the March 31 deadline | Simply Save

How to choose the right tax-saver 80C investments before the March 31 deadline | Simply Save

Starting early and identifying the most suitable section 80C instruments after meticulous research will ensure that your tax-planning is not an isolated activity, but is integrated into your larger goal-based financial planning strategy. Do not wait until March 31 to complete the process as technical glitches on investment portals could derail your plans at the last minute.

Read More

​ Starting early and identifying the most suitable section 80C instruments after meticulous research will ensure that your tax-planning is not an isolated activity, but is integrated into your larger goal-based financial planning strategy. Do not wait until March 31 to complete the process as technical glitches on investment portals could derail your plans at the last minute. Starting early and identifying the most suitable section 80C instruments after meticulous research will ensure that your tax-planning is not an isolated activity, but is integrated into your larger goal-based financial planning strategy. Do not wait until March 31 to complete the process as technical glitches on investment portals could derail your plans at the last minute.  Moneycontrol Latest News Read More  

Starting early and identifying the most suitable section 80C instruments after meticulous research will ensure that your tax-planning is not an isolated activity, but is integrated into your larger goal-based financial planning strategy. Do not wait until March 31 to complete the process as technical glitches on investment portals could derail your plans at the last minute.

hi_INहिन्दी